Portola Pharmaceuticals, Inc. (PTLA) was a big mover last session, as its shares rose over 8% on the day. The rise came on solid volume too with far more shares changing hands than in a normal session. This reverses the downtrend for the company since Feb 25, as it is now down almost 8%.
In the last 30 days, the company witnessed one negative estimate revision and the Zacks Consensus Estimate also moved lower, signaling trouble down the road. So make sure to keep an eye on this stock going forward to see if yesterday’s move higher lasts.
Portola Pharmaceuticals currently has a Zacks Rank #3 (Hold) while its Earnings ESP is negative.
Other better-ranked stocks in the medical sector include WuXi PharmaTech (Cayman) Inc. (WX), BioLineRx, Ltd. (BLRX) and Aratana Therapeutics, Inc. (PETX). All three carry a Zacks Rank #2 (Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
To read this article on Zacks.com click here.
Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.
Be the first to comment